AllovirInc Earnings Before Interest Taxes and Depreciation Amortization EBITDA from 2010 to 2024

ALVR Stock  USD 0.75  0.01  1.32%   
Check AllovirInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AllovirInc main balance sheet or income statement drivers, such as Net Interest Income of 5.5 M, Interest Income of 5.5 M or Depreciation And Amortization of 591.1 K, as well as many exotic indicators such as Price To Sales Ratio of 2.9 K, Dividend Yield of 0.0 or Price Book Value Ratio of 0.51. AllovirInc financial statements analysis is a perfect complement when working with AllovirInc Valuation or Volatility modules.
  
This module can also supplement AllovirInc's financial leverage analysis and stock options assessment as well as various AllovirInc Technical models . Check out the analysis of AllovirInc Correlation against competitors.
To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.

About AllovirInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include AllovirInc income statement, its balance sheet, and the statement of cash flows. AllovirInc investors use historical funamental indicators, such as AllovirInc's Earnings Before Interest Taxes and Depreciation Amortization EBITDA, to determine how well the company is positioned to perform in the future. Although AllovirInc investors may use each financial statement separately, they are all related. The changes in AllovirInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AllovirInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AllovirInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AllovirInc. Please read more on our technical analysis and fundamental analysis pages.
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people.

Pair Trading with AllovirInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AllovirInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AllovirInc will appreciate offsetting losses from the drop in the long position's value.

Moving against AllovirInc Stock

  0.65KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.6MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.6ME 23Andme HoldingPairCorr
  0.56MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.55MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to AllovirInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AllovirInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AllovirInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AllovirInc to buy it.
The correlation of AllovirInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AllovirInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AllovirInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AllovirInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AllovirInc is a strong investment it is important to analyze AllovirInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AllovirInc's future performance. For an informed investment choice regarding AllovirInc Stock, refer to the following important reports:
Check out the analysis of AllovirInc Correlation against competitors.
To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for AllovirInc Stock analysis

When running AllovirInc's price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.83)
Return On Assets
(0.48)
Return On Equity
(1.03)
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if AllovirInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.